01 April 2019

Machines, fixing human disease

Last year we highlighted the secretive juggernaut DREADCO's move into drug discovery. Today they announced the launch of their new division SkyFragNet (not to be confused with the European graduate training program FragNet). Its audacious mission: “to eradicate human disease."

SkyFragNet will automate every aspect of drug discovery. The approach starts with a powerful docking method, in which all 166 billion members of GDB-17 will be docked against a target of interest. Synthetic schemes for the virtual hits will be computationally generated, and the compounds will be synthesized using automated flow synthesis and mass-directed purification.

Fragment hits that confirm in a panel of biophysical techniques will then undergo computational-based growing; SkyFragNet incorporates the latest AI algorithms to maximize the likelihood of success. As with the fragments, designed molecules will be synthesized and tested, first in biochemical and then in cell-based assays.

Although the folks at Mordor State College are trying to make animal testing obsolete, SkyFragNet will still rely on pharmaokinetic and pharmacodynamic studies. However, they have built a fully mechanized vivarium run entirely by robots - think of The Matrix but with mice in place of humans.

Finally, compounds that make it through this gauntlet will be scaled up under GMP conditions (automated, of course) for clinical trials. It remains to be seen how many compounds SkyFragNet will take into the clinic, or whether the success rates will be higher than those of their human counterparts.

Of course, with all this power comes enormous responsibility. If things go wrong, hopefully DREADCO will have the wisdom to Terminate the program. Eradicating human disease could be done in two very different ways.

4 comments:

Unknown said...

That time of year

Peter Kenny said...

The key insight is that a successful drug is one that reduces the number of patients suffering from the symptoms.

U. Hapko said...

Even though I understand Dan's fidelity to the tradition of making posts of this kind at this day of year, the situation described certainly doesn't sound as science fiction or utopia in the long run.
The times may come, when a process chemist/medicinal chemist/biologist etc. would be none other than a technician, under an unblinking eye of whom the job is being done by the highly automated machinery (this includes decision making as well), guided by computer vision in different spectral ranges and supported by databases giving access to all trial and error experience amassed by humankind.
The job of drug discovery will be done in the aforementioned way during the transition period, until disease as a conception is eradicated by artificial elimination of defective genes and mending the undesired mutation will become a matter of a single visit of a drug store.

Dan Erlanson said...

Pete - that's brilliant - perhaps DREADCO will adopt it as their marketing slogan!

U. - My April 1 posts are often only partially in jest, and some of them turn out to be disturbingly accurate.